Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 2Endocrine 2CNS 2Breast 2Sarcoma 1NET 1Gynecologic 1Dermatologic 1

Conditions

Melanoma 19Lymphoma, T-Cell, Cutaneous 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Non-Hodgkin 16Lymphoma, Mantle-Cell 16Lymphoma, Large-Cell, Immunoblastic 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Lymphocytic, Chronic, B-Cell 16Burkitt Lymphoma 16Lymphoma 15Hodgkin Disease 14Sezary Syndrome 13Mycosis Fungoides 13Leukemia 11Multiple Myeloma 10Leukemia, Myeloid, Acute 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Myeloproliferative Disorders 9Myelodysplastic Syndromes 9Lymphoma, Large-Cell, Anaplastic 9Neoplasms, Plasma Cell 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Hairy Cell 7Dendritic Cell Sarcoma, Interdigitating 7Recurrence 6Primary Myelofibrosis 6

Interventions

pembrolizumab 36Cyclophosphamide 24Nivolumab 23Ipilimumab 22aldesleukin 19Interleukin-2 15fludarabine 14Specimen Handling 12Dacarbazine 11fludarabine phosphate 10Magnetic Resonance Spectroscopy 10Temozolomide 9Radiosurgery 9Biopsy 9cemiplimab 8Paclitaxel 8dabrafenib 5binimetinib 5Vemurafenib 5Radiotherapy 5Carboplatin 5trametinib 4sargramostim 4encorafenib 4avelumab 4Pemetrexed 4Leucovorin 4Fluorouracil 4Cisplatin 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Filgrastim × Dermatologic × Clear all
NCT00001832 2012-12-21

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
170 enrolled 23 charts
BreastDermatologic

Breast Neoplasms, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡